CLINICAL_TRIALS
trial_result
· 2021-03-05
Clinical Trial Update: Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) [Phase 2]
Summary
Phase 2 trial investigating maraviroc for HIV-related Kaposi's sarcoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Kaposi's Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2021-03-05